Skip to content

Comparation of propofol and sevoflurane anesthesia on AD related biomarkers and behavioral cognitive effects in AD patients after Lymph Vein Anastomosis: a Randomized Controlled trial

Comparation of propofol and sevoflurane anesthesia on AD related biomarkers and behavioral cognitive effects in AD patients after Lymph Vein Anastomosis: a Randomized Controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091764
Enrollment
Unknown
Registered
2024-11-04
Start date
2024-11-04
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Sevoflurane Group :In the sevoflurane group, intraoperative anesthesia maintenance was achieved using sevoflurane inhalation anesthesia.
Propofol Group:In the propofol group, intraoperative anesthesia maintenance was performed using propofol.

Sponsors

The First People's Hospital of Zunyi
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Meet the clinical diagnostic criteria and symptom staging standards for Alzheimer's disease (AD); (2) Participants must be >50 years old; (3) Disease duration must be >6 months; (4) Clinical Dementia Rating (CDR) scale score must be 2 or 3, indicating moderate or severe dementia; (5) Mini-Mental State Examination (MMSE) score must be 10-15, with accompanying Behavioral and Psychological Symptoms of Dementia (BPSD); (6) No history of psychiatric disorders or epilepsy, and no other severe organ or systemic diseases; (7) American Society of Anesthesiologists (ASA) physical status classification =2; (8) Undergoing LVA surgery under general anesthesia with intubation; (9) Patients and their families have been thoroughly informed about the purpose, significance, expected outcomes, and potential risks of the study and have voluntarily agreed to participate, signing the relevant informed consent forms.

Exclusion criteria

Exclusion criteria: (1) Patients with non-AD or mild AD; (2) Patients with other mental disorders or cognitive impairment due to depression, Parkinson's disease, stroke, etc.; (3) Patients with critical illness (preoperative ASA physical status classification > 3), severe liver dysfunction (Child-Pugh class C), or severe renal insufficiency (preoperative dialysis); (4) Patients who cannot tolerate cervical lymph node-vein anastomosis surgery; (5) Patients with a family history or personal history of malignant hyperthermia, and those with contraindications to sevoflurane or propofol use.

Design outcomes

Primary

MeasureTime frame
A-ß;P-tau;MRI;MMSE;ADAS-cog;ADL;

Countries

China

Contacts

Public ContactZhang Jing

The First People's Hospital of Zunyi

18385338018@125.com+86 183 8533 8018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026